- Previous close
308.23 - Open
308.00 - Bid 319.00 x 800
- Ask 318.25 x 800
- Day's range
308.11 - 316.53 - 52-week range
253.95 - 370.83 - Volume
2,409,796 - Avg. Volume
1,410,942 - Market cap (intra-day)
87.468B - Beta (5Y monthly) 0.51
- PE ratio (TTM)
24.70 - EPS (TTM)
12.67 - Earnings date 31 Oct 2024
- Forward dividend & yield 5.60 (1.79%)
- Ex-dividend date 4 Dec 2024
- 1y target est
397.09
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.
www.cigna.com70,325
Full-time employees
31 December
Fiscal year ends
Healthcare
Sector
Healthcare Plans
Industry
Recent news: CI
View more
Related videos: CI
Performance overview: CI
Trailing total returns as of 30/10/2024, which may include dividends or other distributions. Benchmark is
.YTD return
1-year return
3-year return
5-year return
Compare to: CI
Select to analyse similar companies using key performance metrics; select up to four stocks.
Statistics: CI
View moreValuation measures
Market cap
87.47B
Enterprise value
112.57B
Trailing P/E
24.70
Forward P/E
9.77
PEG ratio (5-yr expected)
0.70
Price/sales (ttm)
0.42
Price/book (mrq)
2.12
Enterprise value/revenue
0.52
Enterprise value/EBITDA
--
Financial highlights
Profitability and income statement
Profit margin
1.72%
Return on assets (ttm)
3.11%
Return on equity (ttm)
9.13%
Revenue (ttm)
216.01B
Net income avi to common (ttm)
3.71B
Diluted EPS (ttm)
12.67
Balance sheet and cash flow
Total cash (mrq)
7.66B
Total debt/equity (mrq)
78.51%
Levered free cash flow (ttm)
1.7B